![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 37, 33571-33579, September 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the George Whipple Laboratory for Cancer Research, Departments
of Pathology, Urology, and the Cancer Center, University of
Rochester Medical Center, Rochester, New York 14642
The transcriptional activity of the estrogen
receptor (ER) is known to be highly modulated by the character and
amount of coregulator proteins present in the cells. TR2 orphan
receptor (TR2), a member of the nuclear receptor superfamily without
identified ligands, is found to be expressed in the breast cancer cell
lines and to function as a repressor to suppress ER-mediated
transcriptional activity. Utilizing an interaction blocker, ER-6 (amino
acids 312-340), responsible for TR2 interaction, the suppression of ER
by TR2 could be reversed, suggesting that this suppression is conferred
by the direct protein-protein interaction. Administration of antisense
TR2, resulting in an enhancement of ER transcriptional activity in MCF7
cells, indicates that endogenous TR2 normally suppresses ER-mediated
signaling. To gain insights into the molecular mechanism by which TR2
suppresses ER, we found that TR2 could interrupt ER DNA binding via
formation of an ER-TR2 heterodimer that disrupted the ER
homodimerization. The suppression of ER transcription by TR2
consequently caused the inhibition of estrogen-induced cell growth and
G1/S transition in estrogen-dependent
breast cancer cells. Taken together in addition to the potential roles
in spermatogenesis and neurogenesis, our data provide a novel
biological function of TR2 that may exert an important repressor in
regulating ER activity in mammary glands.
Suppression of Estrogen Receptor-mediated Transcription and
Cell Growth by Interaction with TR2 Orphan Receptor*
*
This work was supported by National Institutes of Health
Grant DK47258.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: University of
Rochester Medical Center, 601 Elmwood Ave., Box 626, Rochester, NY
14642. Tel.: 585-275-9994; Fax: 585-756-4133; E-mail: chang@urmc.rochester.edu.
This article has been cited by other articles:
![]() |
K. D. Baker, R. B. Beckstead, D. J. Mangelsdorf, and C. S. Thummel Functional interactions between the Moses corepressor and DHR78 nuclear receptor regulate growth in Drosophila Genes & Dev., February 15, 2007; 21(4): 450 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al. International Union of Pharmacology. LXVI. Orphan Nuclear Receptors Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Lin, Y.-C. Hu, D. K. Lee, and C. Chang Regulation of Androgen Receptor Signaling by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Tumor Suppressor through Distinct Mechanisms in Prostate Cancer Cells Mol. Endocrinol., October 1, 2004; 18(10): 2409 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Hu, S. Yeh, S.-D. Yeh, E. R. Sampson, J. Huang, P. Li, C.-L. Hsu, H.-J. Ting, H.-K. Lin, L. Wang, et al. Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer J. Biol. Chem., August 6, 2004; 279(32): 33438 - 33446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Townson, K. Kang, A. V. Lee, and S. Oesterreich Structure-Function Analysis of the Estrogen Receptor {alpha} Corepressor Scaffold Attachment Factor-B1: IDENTIFICATION OF A POTENT TRANSCRIPTIONAL REPRESSION DOMAIN J. Biol. Chem., June 18, 2004; 279(25): 26074 - 26081. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tanmahasamut, J. Liu, L. B. Hendry, and N. Sidell Conjugated Linoleic Acid Blocks Estrogen Signaling in Human Breast Cancer Cells J. Nutr., March 1, 2004; 134(3): 674 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Lin, Y.-C. Hu, L. Yang, S. Altuwaijri, Y.-T. Chen, H.-Y. Kang, and C. Chang Suppression Versus Induction of Androgen Receptor Functions by the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer LNCaP Cells with Different Passage Numbers J. Biol. Chem., December 19, 2003; 278(51): 50902 - 50907. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yeh, Y.-C. Hu, P.-H. Wang, C. Xie, Q. Xu, M.-Y. Tsai, Z. Dong, R.-S. Wang, T.-H. Lee, and C. Chang Abnormal Mammary Gland Development and Growth Retardation in Female Mice and MCF7 Breast Cancer Cells Lacking Androgen Receptor J. Exp. Med., December 15, 2003; 198(12): 1899 - 1908. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |